Temporal Concept
CRISPR Pioneers Jennifer Doudna and Fyodor Urnov Launch Aurora Therapeutics for Custom CRISPR Therapies
Aurora Therapeutics; CRISPR; gene editing; personalized therapies; Jennifer Doudna; Fyodor Urnov; rare diseases; Menlo Ventures
Abivax Stock Surges on Reports of $17.5 Billion Eli Lilly Takeover Interest
Abivax; ABVX; Eli Lilly; takeover bid; stock surge; obefazimod
Independent expert group to review HPV vaccine evidence after US recommendation change
HPV vaccine; Vaccine Integrity Project; independent review; CDC recommendation change; single-dose schedule; ACIP disbanded; CIDRAP; Robert F. Kennedy Jr.; US childhood immunization schedule; Gardasil
GSK and Ionis Announce Phase 3 Success for Bepirovirsen, Potential Functional Cure for Chronic Hepatitis B
GSK; Ionis; bepirovirsen; hepatitis B; Phase 3; functional cure; B-Well trials
Argenx Appoints Karen Massey as New CEO in Leadership Transition
argenx; Karen Massey; CEO; Tim Van Hauwermeiren; leadership transition; rare diseases; Vyvgart
Biotech’s Groove is Back for 2026: XBI Surges Amid M&A Boom and Lower Rates
biotech; XBI; M&A; lower rates; 2026 trends
Orum Therapeutics Appoints Chad May as Chief Scientific Officer
Orum Therapeutics; Chad May; CSO; Degrader-Antibody Conjugates; DAC; Targeted Protein Degradation
Genmab Discontinues Phase III Development of Acasunlimab Lung Cancer Asset Previously Ditched by BioNTech
Genmab; acasunlimab; BioNTech; lung cancer; NSCLC; Phase 3; pipeline review
Shionogi Announces $2.5 Billion Acquisition of ALS Drug Radicava from Tanabe Pharma
Shionogi; Tanabe Pharma; Radicava; ALS; acquisition; $2.5B; rare disease
Spotlight On: Five Key FDA Approvals of 2025
FDA approvals; 2025; orphan drugs; novel therapies; rare diseases